Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jan;98(1):116-122.
doi: 10.1213/01.ANE.0000090147.97636.77.

Are peripheral opioid antagonists the solution to opioid side effects?

John J Bates  1 , Joseph F Foss, Damian B Murphy
Affiliations
Review

Are peripheral opioid antagonists the solution to opioid side effects?

John J Bates et al. Anesth Analg. 2004 Jan.

Abstract

Opioid medication is the mainstay of therapy for severe acute and chronic pain. Unfortunately, the side effects of these medications can affect patient comfort and safety, thus limiting their proven therapeutic potential. Whereas the main analgesic effects of opioids are centrally mediated, many of the common side effects are mediated via peripheral receptors. Novel peripheral opioid antagonists have been recently introduced that can block the peripheral actions of opioids without affecting centrally mediated analgesia. We review the clinical and experimental evidence of their efficacy in ameliorating opioid side effects and consider what further information might be useful in defining their role.

Implications: The major analgesic effects of opioid medication are mediated within the brain and spinal cord. Many of the side effects of opioids are caused by activation of receptors outside these areas. Recently developed peripherally restricted opioid antagonists have the ability to block many opioid side effects without affecting analgesia.

PubMed Disclaimer

References

    1. Machelska H, Stein C. Immune mechanisms in pain control. Anesth Analg 2002; 95: 1002–81.
    1. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 2002; 47: 2222–30.
    1. Tramer MR, Reynolds JM, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of Ondansetron in prevention of postoperative nausea and vomiting. Anesthesiology 1997; 87: 1277–89.
    1. Gairola RL, Gupta PK, Pandley K. Antagonists of morphine-induced respiratory depression: a study in postoperative patients. Anaesthesia 1980; 35: 17–21.
    1. Lehmann KA, Reichling U, Wirtz R. Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine. Eur J Clin Pharmacol 1988; 34: 343–52.

MeSH terms

LinkOut - more resources